NCT06949813

Brief Summary

Perinatal mental health disorders are the most prevalent perinatal comorbidity and are associated with the primary cause of maternal mortality in the United States (US) - suicide. Diagnosis of a high-risk pregnancy and cesarean delivery (CD) are both associated with increased risk for perinatal mood, anxiety, and trauma symptoms (PMATS). There is a deficit in resources and access to mental health treatment for pregnant patients, with some treatments being cost-prohibitive and requiring multiple sessions. Additionally, current approaches to addressing PMATS are reactive rather than preventive. There is evidence in the non-obstetric population that single-session cognitive behavioral therapy interventions targeting anxiety sensitivity (fear of fear) can prevent the development of anxiety and trauma symptoms when individuals are exposed to trauma. The investigators developed a low-cost, 1-hour, single-session prevention intervention that included psychoeducation about anxiety sensitivity, coupled with a brief exposure to the operating room environment and CD procedures. To revise the implementation plan and intervention (CARE: Communication, Agency, Readiness, Empowerment for cesarean delivery \[CD\]) for use in large L\&D units with a broader population of patients, a fully powered multisite randomized control trial (RCT) is needed. Before initiating such a trial, work needs to be done to modify the intervention and implementation through a process of iterative refinement to enhance the acceptability, appropriateness, and feasibility of implementation in L\&D units across the country, as well as its efficacy at engaging with the target mechanism (anxiety sensitivity). Using a logic model to guide the iterative refinement process through fast feedback loops and an atmosphere of co-creation, study investigators will gather critical input from stakeholders (individuals with lived experiences, community partners, front-line clinicians, and hospital staff) via 12 workgroups, 12 user-testing design sessions, and repeated engagement with a steering council. Following this refinement process, a treatment development pilot RCT at a large L\&D unit will assess the efficacy of CARE for CD by probing engagement with the target mechanism, as well as assess the feasibility of implementation. Finally, the updated logic model and pilot trial results will inform the development of a protocol for a multisite RCT through engagement with expert consultants in a community engagement studio and further feedback from the steering council.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Oct 2025Apr 2027

First Submitted

Initial submission to the registry

November 1, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 29, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 13, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

November 1, 2024

Last Update Submit

March 19, 2026

Conditions

Keywords

perinatal mood and anxiety disorderscesarean deliverySingle session immersive interventionRandomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Anxiety-sensitivity Index 3

    18-item scale that yields a primary outcome score and subscale scores. Higher scores indicate higher anxiety sensitivity. Minimum score 0. Maximum score 72.

    Baseline

  • Anxiety-sensitivity Index 3

    18-item scale that yields a primary outcome score and subscale scores. Higher scores indicate higher anxiety sensitivity. Minimum score 0. Maximum score 72.

    Approximately 3 days (range=1-5) after intervention (CARE and interaction control conditions) or approximately 5 days (range = 3-7) after enrollment (care as usual condition)

Secondary Outcomes (21)

  • Adverse Childhood Experience Questionnaire

    Baseline

  • Wijma Delivery Expectancy/Experience Questionnaire

    Baseline

  • State-Trait Anxiety Inventory

    Baseline

  • Columbia Suicide Severity Rating Scale

    Baseline

  • Edinburgh postpartum depression scale

    Baseline

  • +16 more secondary outcomes

Study Arms (3)

Intervention

EXPERIMENTAL

Intervention: (N= 40) Participants will be scheduled to receive the 1-hour, single-session CARE intervention administered by a medical and mental health provider trained in the intervention. CARE will consist of psychoeducation and brief immersive exposure to the operating room.

Behavioral: BE-OR: Brief Intervention to the Operating Room

Interaction Control

EXPERIMENTAL

Interaction Control: (N = 20) Participants will receive a 1-hour, single-session meeting with a nurse educator that will occur within a single patient room on L\&D. This condition will provide the same front-line clinician facetime as the treatment condition but will not include the clinical content of the intervention (psychoeducation + exposure).

Other: Interaction: Facetime with Clinical Provider

Care as Usual

NO INTERVENTION

Care as Usual Control: (N = 20) Participants will receive all the standard prenatal and CD education. The participants will not receive any additional face-to-face interaction with front-line clinicians as part of the study.

Interventions

See Interaction group section for details

Interaction Control

See intervention group section for details

Also known as: CARE-CD: Comfort, Agency, Readiness, Empowerment for Cesarean Delivery
Intervention

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsMust be able to become pregnant, biological female. No exclusion will be made for how a person identifies regarding gender.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant Patients at 22-37 weeks gestation
  • Single or multiple gestation
  • Nulliparous or multiparous (with prior vaginal or cesarean delivery)
  • Antepartum admission for at least 3 days
  • High-risk pregnancy due to maternal/fetal comorbidities
  • Anticipated cesarean delivery at the University of Colorado

You may not qualify if:

  • Lack of capacity to consent
  • Medical factors prohibiting participation in the intervention as determined by the inpatient obstetric medical team.
  • Anticipated cesarean within 7 days of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Hospital

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Cesarean Section

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
After providing informed consent, participants will be randomized (2:1:1) to condition using an Excel spreadsheet uploaded into a REDCap® database. This will ensure allocation concealment. At the time of consent, patients will be informed that the study involves randomization to one of three conditions, two of which involve a one-hour session with one or more clinicians to prepare the participants for delivery. Participants assigned to BE-OR versus Interaction Control conditions will be informed that they are assigned to a condition in which they receive an intervention but will be masked to whether they were assigned to BE-OR or Interaction Control "intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 2:1:1 randomization allocation of 3 study groups. Intervention: (N= 40) Participants will be scheduled to receive the 1-hour, single-session CARE intervention administered by a medical and mental health provider trained in the intervention. CARE will consist of psychoeducation and brief immersive exposure to the operating room. Interaction Control: (N = 20) Participants will receive a 1-hour, single-session meeting with a nurse educator that will occur within a single patient room on L\&D. This condition will provide the same front-line clinician facetime as the treatment condition but will not include the clinical content of the intervention (psychoeducation + exposure). Care as Usual Control: (N = 20) Participants will receive all the standard education. The participants will not receive any additional face-to-face interaction with front-line clinicians as part of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2024

First Posted

April 29, 2025

Study Start

October 13, 2025

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All data will be made available to the scientific community on the date that the grant award period ends. Sharing of materials will be facilitated as part of the normal conduct of collaborative research. All terms will comply with published NIH guidelines for the dissemination of research resources. All resource tools generated in conjunction with this project will be distributed freely and shared with the scientific community via peer-reviewed publications and poster/oral presentations at national/international meetings. The investigators will also openly share unpublished results with the scientific community as opportunity presents and/or the data is requested.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
All data will be made available to the scientific community on the date that the grant award period ends. Sharing of materials will be facilitated as part of the normal conduct of collaborative research. All terms will comply with published NIH guidelines for the dissemination of research resources. All resource tools generated in conjunction with this project will be distributed freely and shared with the scientific community via peer-reviewed publications and poster/oral presentations at national/international meetings. The investigators will also openly share unpublished results with the scientific community as opportunities present and/or the data is requested.
Access Criteria
For all shared data, any interested reseacher can have access to this data through a data use agreement from the university of colorado.
More information

Locations